当前位置： SCI文献检索 > Hepatology International期刊下所有文献 > Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs.

Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs.

Abstract：

PURPOSE:Despite improvements in immunosuppressive therapy, acute cellular rejection (ACR) remains an important cause of graft loss in patients undergoing liver transplantation. Recently, associations between cytokine gene polymorphisms in recipients and the occurrence of ACR have been reported. However, most studies did not investigate gene polymorphisms in donors or were limited by the number of cases investigated. METHODS:We examined 155 living donor liver transplantation (LDLT) patients treated at Nagoya University or Kyoto University from 2004 to 2009. The following gene polymorphisms in recipients and donors were analyzed: tumor necrosis factor A (TNF-A) T-1031C, interleukin 2 (IL-2) T-330G, IL-10C-819T, IL-13C-1111T, and transforming growth factor B (TGF-B) T29C. RESULTS:Forty-seven recipients (30.3 %) developed early ACR. Of the investigated gene polymorphisms, the IL-13 -1111C/C genotype in recipients was significantly associated with a higher incidence of ACR relative to the other two genotypes (OR = 2.64, 95 % CI 1.19-5.86, p = 0.017), while we showed the lack of association between investigated gene polymorphisms in donors and ACR incidence. CONCLUSION:The IL-13 -1111C/C genotype in recipients might be a risk factor for ACR in LDLT, and this might contribute to individualized immunosuppression strategies for recipients. On the other hand, the current study showed no associations of cytokine gene polymorphisms in donors with ACR incidence.

journal_name

Hepatol Int

journal_title

Hepatology international

authors

Kamei H,Masuda S,Nakamura T,Ishigami M,Fujimoto Y,Ogura Y,Oike F,Takada Y,Hamajima N

doi

10.1007/s12072-013-9443-2

subject

Has Abstract

pub_date

2013-07-01 00:00:00

pages

916-22

issue

3

eissn

1936-0533

issn

1936-0541

pii

10.1007/s12072-013-9443-2

journal_volume

7

pub_type

杂志文章

相关文献

Hepatology International文献大全
  • Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study.

    abstract：PURPOSE:There have been reports that radiofrequency ablation (RFA) combined with transarterial chemoembolization (TACE) is as equally effective as surgical resection for the treatment of hepatocellular carcinoma (HCC). This study aimed to evaluate recurrence rate and risk factor of recurrence after RFA combined with TA...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9290-y

    authors： Kim JH,Yim HJ,Lee KG,Kim SY,Jung ES,Jung YK,Kim JH,Seo YS,Yeon JE,Lee HS,Um SH,Byun KS,Ryu HS

    更新日期：2012-04-01 00:00:00

  • Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion.

    abstract：PURPOSE:Microvascular invasion of hepatocellular carcinoma (HCC) is considered a poor prognostic factor of liver resection (LR) and liver transplantation (LT), but its significance for lesions within the up-to-7 criteria is unclear. This study investigated the survival benefit of primary LT against LR for HCC with micr...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9318-3

    authors： Chan SC,Fan ST,Chok KS,Cheung TT,Chan AC,Fung JY,Poon RT,Lo CM

    更新日期：2011-10-21 00:00:00

  • A brief review on prognostic models of primary biliary cholangitis.

    abstract：:Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune liver disease characterized by progressive destruction of small intrahepatic bile ducts. If left untreated, PBC may eventually result in end-stage liver disease. For better management of PBC and optimal allocation of med...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-017-9819-9

    authors： Chen S,Duan W,You H,Jia J

    更新日期：2017-09-01 00:00:00

  • Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.

    abstract：:The prognosis of advanced hepatocellular carcinoma (HCC) remains poor. For patients with advanced HCC, the multikinase inhibitor sorafenib is recommended as the current standard of care. In contrast, hepatic arterial infusion chemotherapy (HAIC) is one of the recommended treatments in Japan. However, in Japan, the use...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-013-9515-3

    authors： Yamasaki T,Saeki I,Sakaida I

    更新日期：2014-09-01 00:00:00

  • Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

    abstract：BACKGROUND AND AIMS:Ultrasonography is the most frequently used modality in surveillance for HCC among patients with chronic hepatitis C. However, the optimal surveillance interval is still controversial and the usefulness of supplementary tumor marker determination has not been confirmed. METHODS:A total of 243 cases...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-009-9145-y

    authors： Sato T,Tateishi R,Yoshida H,Ohki T,Masuzaki R,Imamura J,Goto T,Kanai F,Obi S,Kato N,Shiina S,Kawabe T,Omata M

    更新日期：2009-12-01 00:00:00

  • Magnitude of contrast-enhanced ultrasonography as a noninvasive predictor for hepatic fibrosis: comparison with liver stiffness measurement and serum-based models.

    abstract：PURPOSE:To elucidate the efficiency of contrast-enhanced ultrasonography alone and in combination with other noninvasive models for grading hepatic fibrosis. METHODS:This prospective study included 74 patients with four grades (F1-F4) of chronic liver disease (17, 20, 18, and 19 patients, respectively). Diagnostic per...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9370-7

    authors： Tawada A,Maruyama H,Kamezaki H,Shimada T,Ishibashi H,Takahashi M,Kanda T,Fujiwara K,Imazeki F,Yokosuka O

    更新日期：2013-06-01 00:00:00

  • Reversal of NASH fibrosis with pharmacotherapy.

    abstract：:NAFLD is a spectrum of liver disease starting with fatty liver at one end of the spectrum and cirrhosis or liver cancer at the other end. Worldwide, NAFLD has become one of the most common liver diseases and it has also become one of the leading indications for liver transplantation. Our understanding of the NAFLD epi...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-019-09970-3

    authors： Alukal JJ,Thuluvath PJ

    更新日期：2019-09-01 00:00:00

  • A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection.

    abstract：PURPOSE:Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS:We compared baseline hepatitis B viral markers in 317 pati...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-010-9179-1

    authors： Tong MJ,Hsu L,Hsien C,Kao JH,Durazo FA,Saab S,Blatt LM

    更新日期：2010-04-07 00:00:00

  • The influence of pioglitazone on the plasma amino acid profile in patients with nonalcoholic steatohepatitis (NASH).

    abstract：BACKGROUND AND AIMS:The peroxisome proliferator-activated receptor-γ (PPAR-γ) ligand, piglitazone, enhances the degradation of branched-chain amino acids (BCAAs) in adipose tissue. However, it remains unknown whether pioglitazone influences the plasma amino acids (AA) profile in patients with nonalcoholic steatohepatit...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9395-y

    authors： Kakazu E,Kondo Y,Ninomiya M,Kimura O,Nagasaki F,Ueno Y,Shimosegawa T

    更新日期：2013-06-01 00:00:00

  • Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?

    abstract：:The cancer stem cell (CSC) hypothesis has been disproved in many cancers. CSCs may exist in blood cancer, while many epithelial cancers may not have CSCs but tumor-initiating cells (TICs). Several independent studies have provided strong evidence for existence of CSCs in brain, skin, and colon cancers (Mani et al. in ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-016-9777-7

    authors： Machida K

    更新日期：2017-03-01 00:00:00

  • An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence.

    abstract：PURPOSE:The diagnostic potential of hepatic stellate cells (HSCs) and γδT cells for patients with hepatocellular carcinoma (HCC) and their synergistic contributions to the prognosis of these patients have not yet been investigated. The aim of this study was to elucidate the prognostic value of these cells in HCC. METH...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-019-09969-w

    authors： Zhou BY,Gong JH,Cai XY,Wang JX,Luo F,Jiang N,Gong JP,Du CY,Liao R

    更新日期：2019-09-01 00:00:00

  • Chinese guidelines on the management of ascites and its related complications in cirrhosis.

    abstract：:The Chinese Society of Hepatology developed the current guidelines for the Management of Ascites and Its Related Complications in Cirrhosis based on the published evidences and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of cirrhotic ascites emphasizing a step-wis...

    journal_title：Hepatology international

    pub_type： 社论,实务指引

    doi：10.1007/s12072-018-09923-2

    authors： Chinese Society of Hepatology, Chinese Medical Association.,Xu X,Duan Z,Ding H,Li W,Jia J,Wei L,Linghu E,Zhuang H

    更新日期：2019-01-01 00:00:00

  • Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis.

    abstract：:Non-alcoholic fatty liver disease (NAFLD) is currently one of the leading forms of chronic liver disease, and its rising frequency worldwide has reached epidemic proportions. NAFLD, particularly its progressive variant NASH (non-alcoholic steatohepatitis), can lead to advanced fibrosis, cirrhosis, and HCC. The pathoph...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-018-9854-1

    authors： Kovalic AJ,Satapathy SK,Chalasani N

    更新日期：2018-03-01 00:00:00

  • Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.

    abstract：:Hepatitis B virus (HBV) reactivation with hepatic decompensation leading to acute on chronic liver failure is not uncommon. It is associated with high mortality of up to 30-70%. Prognostic factors for mortality include high bilirubin level, more prolonged prothrombin time, low platelet count and presence of pre-existi...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-014-9569-x

    authors： Yuen MF

    更新日期：2015-07-01 00:00:00

  • The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a long-term follow-up.

    abstract：BACKGROUND:Early prediction of lamivudine (LAM) response by individualized monitoring of serum HBV DNA like roadmap concept, and investigation of the outcome after LAM discontinuation in renal transplant recipients (RTRs) with chronic hepatitis B (CHB). METHODS:We conducted a study on 19 RTRs with HBV infection receiv...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9295-6

    authors： Hu TH,Tsai MC,Chen YT,Chien YS,Hung CH,Chen TC,Tseng PL,Chang KC,Yen YH

    更新日期：2012-04-01 00:00:00

  • Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients.

    abstract：BACKGROUND AND OBJECTIVE:Cytokines have been reported to be involved in the cirrhosis and hepatic encephalopathy (HE). Many aspects on the correlation between minimal HE (MHE) and cytokine levels were still unclear. METHODS:Two hundred eighty-nine HBV-infected cirrhotic patients were grouped: non MHE (n = 156), MHE (n...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-015-9610-8

    authors： Li W,Li N,Wang R,Li Q,Wu H

    更新日期：2015-04-01 00:00:00

  • Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

    abstract：:Substantial advancements in the field of primary biliary cirrhosis (PBC) research have broadened our understanding of this enigmatic disease. Genome-wide studies have identified several new candidate genes involved in the immunoregulatory process, particularly those responsible for antigen presentation and lymphocyte ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9362-7

    authors： Trivedi PJ,Cullen S

    更新日期：2013-03-01 00:00:00

  • Hepatitis B reactivation after chemotherapy: two decades of clinical research.

    abstract：:Hepatitis due to hepatitis B virus reactivation after cytotoxic or immunosuppressive therapy is a serious cause of liver-related morbidity and mortality. With the characterization of the underlying pathogenesis, much progress in the management of this important clinical problem has been made in the past 2 decades. By ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9056-3

    authors： Lau GK

    更新日期：2008-06-01 00:00:00

  • Management of primary sclerosing cholangitis and its complications: an algorithmic approach.

    abstract：:Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease, characterized by multiple strictures and dilatations of the intra- and extrahepatic bile ducts, leading to progressive liver fibrosis, in 10-15% cholangiocarcinoma, and ultimately end-stage liver disease. The pathogenesis is poorly understood, b...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-020-10118-x

    authors： Prokopič M,Beuers U

    更新日期：2020-12-30 00:00:00

  • p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis.

    abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is one of the most common malignant neoplasms worldwide. The p53 gene is frequently mutated in some histological subtypes of HCC. The role of p53 mutations and polymorphic variant of codon 72 in the prognosis of disease is still unclear. The p53 tumor suppressor gene Arg72Pro p...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9389-9

    authors： Jia S,Tang W,Luo Y

    更新日期：2013-06-01 00:00:00

  • Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay.

    abstract：BACKGROUND:Possible serologic activity after hepatitis B surface antigen (HBsAg) seroclearance documented by conventional assays in chronic hepatitis B (CHB) has not been thoroughly investigated. METHODS:We determined the levels of serum hepatitis B virus (HBV) DNA, hepatitis B core-related antigen (HBcrAg), and linea...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9354-7

    authors： Seto WK,Tanaka Y,Wong DK,Lai CL,Shinkai N,Yuen JC,Tong T,Fung J,Hung IF,Yuen MF

    更新日期：2012-03-13 00:00:00

  • Different aspects of CD4 T cells that lead to viral clearance or persistence of HCV infection.

    abstract：:More than 170 million people worldwide are infected with hepatitis C virus (HCV). A characteristic of this virus is a high tendency toward chronic infection. Several factors affect the viral outcome after infection. Among them, HCV-specific CD4 T cells are thought to play a crucial role in controlling viremia. Cumulat...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9321-8

    authors： Sugimoto K,Shiraki K

    更新日期：2012-01-01 00:00:00

  • Virus-induced hepatocellular carcinoma with special emphasis on HBV.

    abstract：:Hepatocellular carcinoma (HCC) is a common malignant tumor with high lethality, and the hepatitis B virus (HBV) is a chief cause. HBV can accelerate HCC via multiple mechanisms. First, HBV induces immune reactions that lead to repeated hepatic inflammation, fibrosis and a deficient immune microenvironment. Subsequentl...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-016-9779-5

    authors： Wang M,Xi D,Ning Q

    更新日期：2017-03-01 00:00:00

  • End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.

    abstract：BACKGROUND AND AIMS:Status 1A patients are prioritized over end-stage liver disease (ESLD) for liver transplantation (LT). ESLD patients with high MELD may have higher waitlist mortality than Status 1A patients, and may require LT more urgently. METHODS:Using United Network for Organ Sharing registry data, we retrospe...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-016-9735-4

    authors： Ahn J,Bhuket T,Mosadeghi S,Frenette C,Liu B,Wong RJ

    更新日期：2016-09-01 00:00:00

  • Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis.

    abstract：BACKGROUND AND AIMS:The liver plays a key role in the storage, metabolism and homeostasis of fat-soluble vitamins. We investigated the relation of Vitamin(Vit)A/D/E serum levels with severity of liver disease and portal hypertension (PHT). METHODS:VitA/D/E serum levels were assessed in 234 patients with advanced chron...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-020-10112-3

    authors： Simbrunner B,Semmler G,Stadlmann A,Scheiner B,Schwabl P,Paternostro R,Bucsics T,Bauer D,Eigenbauer E,Pinter M,Stättermayer AF,Quehenberger P,Marculescu R,Trauner M,Mandorfer M,Reiberger T

    更新日期：2020-12-01 00:00:00

  • Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.

    abstract：BACKGROUND AND AIM:Relationships between circulating microRNA-122 (miR-122) and histological features of nonalcoholic fatty liver disease (NAFLD) are unclear. METHODS:The impact of serum miR-122 levels for histological features and hepatocellular carcinoma (HCC) was investigated in 305 Japanese patients with histologi...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-016-9729-2

    authors： Akuta N,Kawamura Y,Suzuki F,Saitoh S,Arase Y,Kunimoto H,Sorin Y,Fujiyama S,Sezaki H,Hosaka T,Kobayashi M,Suzuki Y,Kobayashi M,Ikeda K,Kumada H

    更新日期：2016-07-01 00:00:00

  • Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.

    abstract：:In patients with chronic hepatitis B (CHB), liver fibrosis assessment is essential not only for determining prognosis but also for identifying patients who should receive treatment. Liver biopsy is limited by its invasiveness and sampling error. To explore effective non-invasive methods for liver fibrosis assessment, ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-013-9439-y

    authors： Chen YP,Peng J,Hou JL

    更新日期：2013-06-01 00:00:00

  • Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

    abstract：:Chronic hepatitis B virus (HBV) infection is endemic in the Asian-Pacific region, and reactivation of HBV post-cancer chemotherapy has become an emerging clinical challenge. Patients with detectable serum HBV DNA before chemotherapy and those receiving intensive chemotherapy are particularly at a risk of HBV reactivat...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9279-6

    authors： Liu CJ,Chen PJ,Chen DS,Kao JH

    更新日期：2013-06-01 00:00:00

  • Outcomes of patients with chest tube insertion for hepatic hydrothorax.

    abstract：PURPOSE:Case reports and small case series have reported a high rate of complications associated with chest tube placement for hepatic hydrothorax. We describe the in-hospital and 3-month outcomes of patients who have had this procedure. METHODS:A retrospective medical record review was performed of all patients admit...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-009-9136-z

    authors： Orman ES,Lok AS

    更新日期：2009-12-01 00:00:00

  • Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury.

    abstract：PURPOSE:Ethanol binge augments liver injury after chronic ethanol consumption in humans, but the mechanism behind the enhanced liver injury by ethanol binge is not known. In this study we used a clinically relevant rat model in which liver injury is amplified by binge after chronic ethanol treatment and investigated th...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-014-9546-4

    authors： Aroor AR,Restrepo RJ,Kharbanda KK,Shukla SD

    更新日期：2014-09-01 00:00:00